News - News - MicroPort® CardioFlow

News

Always Share with You
Every Bit of Our Progress

News

2019.08.28

First “Post-marketing”Implantation for the Procedure Performed by Professor GE on August 28, 2019

Read More
2018.12.12

VitaFlow^® II System of MicroPort^® CardioFlow Has Been Admitted into the “Green Path”

Read More
2018.12.11

First Patient Enrollment Was Successfully Completed for the Pre-market Clinical Research in Europe on VitaFlow^® II Transcatheter Aortic Valve and Retrievable Delivery System of MicroPort^® CardioFlow

In Galway, Ireland on December 11, 2018, Shanghai MicroPort® CardioFlow Medtech Co., Ltd. (hereinafter referred to as “MicroPort® CardioFlow”) announced that the first patient enrollment was completed in Europe for the project of pre-market clinical research on its self-developed VitaFlow® II Transcatheter Aortic Valve and Recyclable Delivery System (hereinafter referred to as “VitaFlow™ II System”) (“VITALE” project for short).

Read More
2018.08.11

VitaFlow^® Has Been Admitted into the “Green Path”

Shanghai, China - VitaFlow® Transcatheter Aortic Valve and Delivery System ("VitaFlow®"), in-house developed by MicroPort CardioFlow has been admitted into the "Green Path" by the China Food and Drug Administration ("CFDA"), a special fast-track procedure for innovative medical devices to gain CFDA approval.

Read More
2018.03.22

MicroPort^® CardioFlow Releases One-year Clinical Outcome of VitaFlow^®

Suzhou, China – From March 22 to March 25, MicroPort® Shanghai CardioFlow Medtech Co., Ltd. ("MicroPort® CardioFlow"), a wholly owned subsidiary of Shanghai MicroPort® Medical (Group) Co., Ltd. ("MicroPort®"), attended CIT 2018 and released the one-year clinical outcome of VitaFlow® Transcatheter Aortic Valve and Delivery System ("VitaFlow®").

Read More

<11 12 13 14 15 16 17 >

Privacy settings

This website may store cookies on your browser. Cookies are mostly used to make the website work asyou expect it to. No cookie will directly identify you, but it can give you a more personalized browsingexperience.

CardioFlow Medtech respects your privacy rights, so you can block some types of cookies. Technically non-essentialcookies and tracking mechanisms, that enable us to provide you with customized offers (marketingcookies), are only used if you have given prior consent to such use.

Strictly necessary cookies

Consent to marketing cookies

By clicking "Save", only the cookies you selected will be used. You can withdraw the consent that you granted here at any time by going to Cookies Settings. For more information, please see our Cookie Policy.

TOP

互联网药品信息服务资格证书编号：（沪）-非经营性 - 2024 - 0135

“MicroPort CardioFlow”及“ are registered trademarks of MicroPort CardioFlow Medtech Corporation.